Med-X, Inc. (MXRX)

Med-X was planning to go public, but the IPO was withdrawn on Apr 23, 2024.

IPO Price Range

$4.00 - $6.00

Shares Offered

1,150,000

Deal Size

$5.75M

Med-X Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1.4	1.01	1.03
Revenue Growth	-	-2.26%	-
Gross Profit	0.23	0.13	0.16
Operating Income	-7.57	-5.23	-3.53
Net Income	-7.58	-4.91	-3.54

Cash & Debt

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	0.62	1.37	0.75
Total Debt	1.16	1.21	1.74
Net Cash (Debt)	-0.54	0.16	-0.99
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-5.4	-4.41	-3.3
Capital Expenditures	-0.09	-0.04	-0
Free Cash Flow	-5.49	-4.45	-3.31
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	16.08%	12.94%	15.79%
Operating Margin	-541.25%	-517.47%	-341.60%
Pretax Margin	-541.35%	-485.68%	-342.54%
Profit Margin	-541.35%	-485.68%	-342.54%
FCF Margin	-392.10%	-440.57%	-319.75%